Zhao, X.,
Sun, J.,
Su, W.,
Shan, H.,
Zhang, B.,
Wang, Y.,
Shabanova, A.,
Shan, H.,
Liang, H. (2018) fibroblasts. Additionally, we determined that luzindole, a melatonin receptor
inhibitor, reduced the anti
Chu, Q.,
Jiang, Y.,
Zhang, W.,
Xu, C.,
Du, W.,
Tuguzbaeva, G.,
Qin, Y.,
Li, A.,
Zhang, L.,
Sun, G.,
Cai, Y.,
Feng, Q.,
Li, G.,
Li, Y.,
Yang, B. (2016) both in vitro and in vivo, which was attenuated by caspase-1
inhibitor Ac-YVAD-CMK. Conclusively
Spasov, AA,
Kucheryavenko, AF,
Khaliullin, FA,
Gurova, NA,
Sirotenko, VS,
Samorodov, AV,
Gaidukova, KA,
Pavlov, VN (2022) administered intravenously was 1.2 times less effective, in terms of ED50, than the well-known
inhibitorYang, F.,
Yang, L.,
Li, Y.,
Yan, G.,
Feng, C.,
Liu, T.,
Gong, R.,
Yuan, Y.,
Wang, N.,
Idiiatullina, E.,
Bikkuzin, T.,
V.N. Pavlov,
Li, Y.,
Dong, C. (2017) by its
inhibitor luzindole. Also, melatonin protected BMSCs against iron overload-induced ROS
YUE, E.,
TUGUZBAEVA, G.M.,
CHEN, X.,
LI, A.,
SUN, X.,
DONG, C.,
LIU, Y.,
YU, Y.,
ZAHRA, S.M.,
JIANG, Y.,
BAI, Y.,
QIN, Y.,
SHAN, Q.,
DU, Z. (2019) expression of NLRP3, caspase-1, and IL-1β. Upon administration of caspase-1
inhibitors, anthocyanin
Guan, XX,
Zhang, YW,
Gareev, I,
Beylerli, O,
Li, XY,
Lu, GT,
Lv, L,
Hai, X (2021) completely reversed the inflammatory response. Knockdown of miR-499a by its specific
inhibitor in healthy
Mingyu, He,
Gege, Yan,
Yang, Wang,
Gong, Rui,
Lei, Hong,
Yu, Shuting,
He, Xiaoqi,
Li, Guanghui,
Du, Weijie,
Ma, Tianshuai,
Gao, Manqi,
Yu, Meixi,
Liu, Shenzhen,
Xu, Zihang,
Idiiatullina, Elina,
Zagidullin, Naufal,
Pavlov, Valentin,
Cai, Benzhi,
Yuan, Ye,
Yang, Lei (2021) -tumour activities of blue LED irradiation. Next, ROS scavenger N-acetyl-L-cysteine (NAC) and NOX
inhibitorCAI, B.,
MA, W.,
WANG, X.,
SUKHAREVA, N.,
HUA, B.,
ZHANG, L.,
LI, X.,
LI, S.,
LIU, S.,
YU, M.,
XU, Y.,
SONG, R.,
XU, B.,
YANG, F.,
HAN, Z.,
DING, F.,
HUANG, Q.,
YU, Y.,
ZHAO, Y.,
WANG, J.,
BAMBA, D.,
PAN, Z.,
YANG, B.,
XU, J.,
ZAGIDULLIN, N.,
LI, F.,
TIAN, Y. (2020) ) phosphorylation and reduced its nuclear translocation by binding PP1A. Verteporfin, a YAP1
inhibitor decreased Lnc
Baltina, L.A.,
Hour, M.-J.,
Liu, Y.-C.,
Chang, Y.-S.,
Huang, S.-H.,
Lai, H.-C.,
Kondratenko, R.M.,
Petrova, S.F.,
Yunusov, M.S.,
Lin, C.-W. (2021) . This report is devoted to the study of glycyrrhizic acid (GL) derivatives as ZIKV
inhibitors. The inhibitory